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STATE-OF-THE-ART PAPER STATE-OF-THE-ART PAPER1031Cardiorenal SyndromeClaudio Ronco, Mariantonietta Cicoira, Peter A. McCullough
Cardiorenal syndrome (CRS) type 1 is characterized by the development of acute kidney
injury and dysfunction in a patient with acute cardiac illness, most commonly acute
decompensated heart failure (ADHF). Ronco and colleagues review the multiple
pathophysiological mechanisms operating simultaneously and sequentially to result in the
clinical syndrome characterized by oliguria, diuretic resistance, and in many cases, worsening
of ADHF symptoms. Hemodynamic changes leading to venous renal congestion,
neurohormonal activation, hypothalamic-pituitary stress reaction, inflammation, systemic
endotoxemic exposure, and iatrogenesis all contribute to CRS type 1. The final common
pathway of bidirectional organ injury appears to be cellular, tissue, and systemic oxidative
stress, which degrades organ function.CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGY104315% of Patients Have Major Vascular Complications With First-Generation TAVRPhilippe Généreux, John G. Webb, Lars G. Svensson, Susheel K. Kodali, Lowell Satler, William F. Fearon,
Charles J. Davidson, Andrew C. Eisenhauer, Raj R. Makkar, Geoffrey Bergman, Vasilis Babaliaros,
Joseph E. Bavaria, Omaida C. Velazquez, Mathew R. Williams, Irene Hueter, Ke Xu, Martin B. Leon,
on behalf of the PARTNER Trial Investigators
Généreux and colleagues sought to identify the incidence, predictors, and impact of vascular
complications (VC) after transfemoral (TF) transcatheter aortic valve replacement (TAVR) by
reviewing data from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. A
total of 419 subjects were treated in this trial with a first-generation Edwards-Sapien valve
(Edwards Lifesciences, Irvine, California) delivered via a 22- or 24-F sheath. A total of 15%
of subjects had major VC, and 12% had minor VC within 30 days. Among subjects with
major VC, vascular dissection (63%), perforation (31%) and access-site hematoma (23%) were
the most frequent. Major VC, but not minor VC, were associated with significantly higher
30-day and 1-year mortality. The only identifiable independent predictor of major VC was
female sex (hazard ratio:  2.31). Major VC were frequent after TF-TAVR in the
PARTNER trial using first generation devices and these complications were associated with
higher mortality.(continued on page A-24)
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1053Benefits for Both Exercise and Pharmacological Treatment
for Cardiac Patients With DepressionJames A. Blumenthal, Andrew Sherwood, Michael A. Babyak, Lana L. Watkins, Patrick J. Smith,
Benson M. Hoffman, C. Virginia F. O’Hayer, Stephanie Mabe, Julie Johnson, P. Murali Doraiswamy,
Wei Jiang, Douglas D. Schocken, Alan L. Hinderliter
Although there is good evidence that clinical depression is associated with poor prognosis in
patients with coronary heart disease, the optimal therapeutic strategies are not known. The
UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy)
trial compared exercise and antidepressant medication for reducing depressive symptoms and
improving cardiovascular biomarkers. Participants were randomized to 4 months of aerobic
exercise (3 times/week), sertraline (50 to 200 mg/day), or placebo. After 16 weeks, all groups
showed improvement in depression rating scores, but greater improvement for those assigned
to either aerobic exercise or sertraline than placebo. Exercise and sertraline were equally
effective in reducing depressive symptoms, and both showed improvement in heart rate
variability compared to placebo.Editorial Comment: Alan Rozanski, p. 1064CARDIOMYOPATHY
1067Longitudinal Left Ventricular Strain Improves Risk Stratification
in Patients With Systemic Light-Chain AmyloidosisSebastian J. Buss, Mostafa Emami, Derliz Mereles, Grigorios Korosoglou, Arnt V. Kristen, Andreas Voss,
Dieter Schellberg, Christian Zugck, Christian Galuschky, Evangelos Giannitsis, Ute Hegenbart,
Anthony D. Ho, Hugo A. Katus, Stefan O. Schonland, Stefan E. Hardt
The aim of this study was to determine whether longitudinal left ventricular (LV) function
provides prognostic information in patients with systemic light chain amyloidosis. A total of
206 consecutive patients with biopsy proven light-chain amyloidosis underwent
echocardiograms, including mean tissue Doppler derived longitudinal strain (LS) and
2-dimensional global longitudinal strain (2D-GLS). During follow-up, LS and 2D-GLS
both offered significant incremental information for predicting outcomes compared to clinical
variables (age, Karnofsky index and New York Heart Association [NYHA] functional class)
and serological biomarkers. This study shows that reduced LV longitudinal function serves as
an independent predictor of survival in amyloidosis.
Editorial Comment: C. Cristina Quarta, Rodney H. Falk, p. 1077(continued on page A-25)
SEPTEMBER 18, 2012 (continued) A-25CARDIAC IMAGING1079Renal Artery Calcification May be Useful Risk MarkerDena E. Rifkin, Joachim H. Ix, Christina L. Wassel, Michael H. Criqui, Matthew A. Allison
Rifkin and colleagues reviewed whole body computed tomography scans obtained as part of a
preventive medicine assessment to assess the relationship between renal artery calcification
(RAC) and cardiac risk. RAC was present in 14% of the nearly 5,000 subjects. After
adjustment for age, gender, diabetes, smoking, cholesterol and family history of CVD, the
presence of RAC conferred a more than 60% increased hazard for all-cause mortality. Adding
RAC to a model including Framingham risk and coronary artery calcium improved the
predictive ability of the model, from 0.73 to 0.77 with a net reclassification index of 14.4%.
These results suggest that RAC may be useful for risk stratification.CARDIAC IMAGING
1086Duration of Early Systolic Lengthening on
Resting Echocardiogram Predicts the Presence of CADMarit Kristine Smedsrud, Sebastian Sarvari, Kristina H. Haugaa, Ola Gjesdal, Stein Ørn, Lars Aaberge,
Otto A. Smiseth, Thor Edvardsen
Ischemic myocardium with reduced active force will lengthen when left ventricular (LV)
pressure is rising during early systole before onset of systolic shortening. Smedsrud and
colleagues investigated whether the duration of LV early systolic lengthening on resting
echocardiograms could accurately identify patients with significant coronary artery disease
(CAD). The duration of early systolic lengthening was significantly prolonged in those with
CAD found during angiography. Prolonged duration of early systolic lengthening showed the
best accuracy in detecting CAD, with an area under the receiver-operating characteristic curve
of 0.83. At 1-year follow-up, the duration of early systolic lengthening was significantly
reduced in the patients treated with revascularization.(continued on page A-26)
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1094CMR May Obviate the Need for Routine Cardiac Catheterization
in Single Ventricle Patients Prior to FontanMark A. Fogel, Thomas W. Pawlowski, Kevin K. Whitehead, Matthew A. Harris, Marc S. Keller,
Andrew C. Glatz, Winnie Zhu, David Shore, Laura K. Diaz, Jonathan J. Rome
Fogel and colleagues investigated whether cardiac magnetic resonance (CMR) and
echocardiography (echo) can replace cardiac catheterization for routine evaluation prior to
Fontan. Data was reviewed from 119 consecutive patients who underwent CMR alone, cath
alone, or both prior to Fontan. CMR added information in 82%. There were no discrepant
findings between CMR and catheterization data. Echo could not delineate pulmonary arterial
anatomy in approximately 50% of patients. The authors recommend that catheterization
should be performed if: 1) noninvasive evaluation reveals need for potential interventions;
2) ventricular function/hemodyamics appear poor on noninvasive studies; 3) Ro criteria are
met with CMR; 4) CMR is contraindicated; or 5) noninvasive imaging methods cannot
obtain necessary information.PRE-CLINICAL RESEARCH PRE-CLINICAL RESEARCH1103Improving Cx43 Expression May Reduce Risk of Post-Infarction ArrhythmiasIan D. Greener, Tetsuo Sasano, Xiaoping Wan, Tomonori Igarashi, Maria Strom, David S. Rosenbaum,
J. Kevin Donahue
Greener and colleagues used a porcine model to evaluate the links between connexin43
(Cx43) expression, myocardial conduction velocity, and ventricular tachycardias in a model of
healed myocardial infarction. A total of 20 animals with reproducibly inducible sustained
monomorphic ventricular tachycardia after anterior infarction were randomized 2:1:1 to
receive AdCx43, Adgal or no gene transfer. Animals receiving AdCx43 had less electrogram
fractionation and faster conduction velocity in the borderzone. Only 40% of AdCx43 animals
remained inducible, while 100% of controls did. Connexin43 gene transfer represents a novel
treatment strategy for post-infarction arrhythmias.Editorial Comment: Jeffrey E. Saffitz, André G. Kléber, p. 1111
